SCHEMBL3871389

SCHEMBL3871389

CCOC(=O)CC(N)c1ccc(N)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
HTT P42858 1/20 0.46
CPB2 Q96IY4 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.40
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
GABRA4 P48169 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3871390 1.00 KDM4E (0.46) KDM4EALDH1A1HTTCPB2SMN1; SMN2
Hydrochloric Acid SCHEMBL7945880 0.99 KDM4E (0.45) KDM4EALDH1A1HTTCPB2SMN1; SMN2
SCHEMBL3861556 0.84 MAPT (0.47) KDM4EALDH1A1HTTSMN1; SMN2F2
SCHEMBL20153392 0.83 NNMT (0.43) KDM4EALDH1A1HTTSMN1; SMN2F2
SCHEMBL6106081 0.83 NNMT (0.43) KDM4EALDH1A1HTTSMN1; SMN2F2
SCHEMBL20154368 0.82 SMN1; SMN2 (0.41) KDM4EALDH1A1HTTSMN1; SMN2F2
SCHEMBL20140958 0.82 SMN1; SMN2 (0.41) KDM4EALDH1A1HTTSMN1; SMN2F2
SCHEMBL24168507 0.81 KDM4E (0.42) KDM4EALDH1A1HTTSMN1; SMN2F2
Hydrochloric Acid SCHEMBL25412612 0.80 KDM4E (0.41) KDM4EALDH1A1HTTSMN1; SMN2F2
SCHEMBL17389437 0.79 CPB2 (0.49) KDM4EALDH1A1HTTCPB2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1047425-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-04-22 EP disclosed
EP-1040111-B1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2005-06-22 EP disclosed
EP-1047425-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-11-02 EP disclosed
EP-1040111-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-10-04 EP disclosed
WO-1999030709-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed
WO-1999031099-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed